Lilly’s Orforglipron Shows Significant Weight Loss in Phase 3 Trial
Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.
Clicks Interim Results Driven by Loyalty and Digital Sales
Read about the Clicks interim results that reveal a 13.2% rise in headline earnings per share and significant market achievements.
Trump Drug Price Executive Order Targets Medicare Negotiations
Get insights on the Trump drug price executive order and how it may reshape timelines for drug price negotiations.
Mediclinic AI Strategy Targets R2 Billion Savings Amid Job Freezes
Explore the Mediclinic AI strategy aimed at R2 billion in savings by 2027 through Artificial Intelligence integration.
African Pharmaceutical Procurement: A Path to Self-Sufficiency
...